Edesa Biotech EDSA
NASDAQ EDSA
$3.86 -0.15 (-3.74%)
At close: Oct 2, 2026 · 4:00 PM EDT

Edesa Biotech (EDSA) Depreciation & Amortization (CF) (2013 - 2025)

Updated

Edesa Biotech's Depreciation & Amortization (CF) was $25,460 in fiscal Q1 2026 (quarter ended Dec 31, 2025), down 40.9% from $43,109 a year earlier and down 1.6% from the prior quarter.

Analysis

Edesa Biotech (EDSA) Depreciation & Amortization (CF) (2013 - 2025) Analysis & Trends

On a trailing twelve-month basis, Edesa Biotech's Depreciation & Amortization (CF) was $101,624 through Dec 31, 2025, down 44.8% year-over-year; for FY2025 (ended Sep 30, 2025), it was $119,273, down 35.9% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
  • In earlier fiscal years, Depreciation & Amortization (CF) was $186,049 in FY2024 (+1.4%), $183,471 in FY2023 (+55.2%), $118,188 in FY2022 (-0.5%) and $118,788 in FY2021 (+106.4%).
  • Quarterly Depreciation & Amortization (CF) has moved between $24,509 (fiscal Q2 2025) and $82,999 (fiscal Q3 2023) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for seven straight quarters, with an average decline of 19.8% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was fiscal Q3 2023 (growth of 180.4%); the worst was fiscal Q3 2021 (a decline of 100.0%).
  • Per Business Quant data, EDSA's Depreciation & Amortization (CF) in the three fiscal quarters before Q1 2026 was $25,868 (Q4 2025), $25,787 (Q3 2025) and $24,509 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Edesa Biotech 38.63 Mn 38.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 25,460.00
Sep 30, 2025 25,868.00
Jun 30, 2025 25,787.00
Mar 31, 2025 24,509.00
Dec 31, 2024 43,109.00
Sep 30, 2024 44,206.00
Jun 30, 2024 51,415.00
Mar 31, 2024 45,397.00
Dec 31, 2023 45,031.00
Sep 30, 2023 45,970.00
Jun 30, 2023 82,999.00
Mar 31, 2023 27,305.00
Dec 31, 2022 27,197.00
Sep 30, 2022 28,960.00
Jun 30, 2022 29,595.00
Mar 31, 2022 29,881.00
Dec 31, 2021 29,752.00
Sep 30, 2021 28,935.00
Jun 30, 2021 31,206.00
Mar 31, 2021 29,804.00
API Access

Edesa Biotech Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EDSA&period=max&api_key=YOUR_API_KEY